Number of Shares
1,275.00
Current Holdings Value*
$78,310.00
% of Portfolio
0.33%
Total Estimate Gain
$77,481.10
% of Total Estimate Gain
62.33%

ULTRA SMALL CAP PROFUND's Halozyme Therapeutics Inc Holding Summary

As of 2025-04-30, ULTRA SMALL CAP PROFUND held 1,275.00 shares of Halozyme Therapeutics Inc(HALO), totaling $78,310.00. This investment constitutes 0.33% of their stock portfolio, and ULTRA SMALL CAP PROFUND now holds 0% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2019Q4. And since then ULTRA SMALL CAP PROFUND has made 7 purchases of HALO, at an average price of $30.22, for a total of 4,113.00 shares. In addition, there have been 10 sales at an average price of $45.13 for 2,838.00 shares. Based on historical transaction data and HALO's current price of $57.81, ULTRA SMALL CAP PROFUND's estimated gain on his HALO holdings is $77,481.10, reflecting a 62.33% gain to date.

ULTRA SMALL CAP PROFUND HALO ($57.81) Holding Chart

ULTRA SMALL CAP PROFUND HALO ($57.81) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1